Teva Pharmaceutical Industries Ltd.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 4.1% | 4.1% | 0.9% |
| FY2022 | -31.3% | -31.3% | -5.6% |
| FY2023 | -7.4% | -7.4% | -1.3% |
| FY2024 | -30.5% | -30.5% | -4.2% |
| FY2025 | 17.8% | 17.8% | 3.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 4.1% | 4.1% | 0.9% |
| FY2022 | -31.3% | -31.3% | -5.6% |
| FY2023 | -7.4% | -7.4% | -1.3% |
| FY2024 | -30.5% | -30.5% | -4.2% |
| FY2025 | 17.8% | 17.8% | 3.5% |